Whole Exome- and mRNA-Sequencing of an AT/RT Case Reveals Few Somatic Mutations and Several Deregulated Signalling Pathways in the Context of <i>SMARCB1</i> Deficiency

<div>(a) MR scan of patient before operation. (b) Immunohistochemical INI1 staining of the tumour tissue. Staining for INI1 was negative in the tumour cells but positive in endothelial and inflammatory cells.</div>

BioMed Research International

fig1

Figure 1

Figure 1: Whole Exome- and mRNA-Sequencing of an AT/RT Case Reveals Few Somatic Mutations and Several Deregulated Signalling Pathways in the Context of <i>SMARCB1</i> Deficiency 

Figure 1 | Whole Exome- and mRNA-Sequencing of an AT/RT Case Reveals Few Somatic Mutations and Several Deregulated Signalling Pathways in the Context of SMARCB1 Deficiency 